Article Correctness Is Author's Responsibility: Endocrine Society updates osteoporosis Clinical Practice Guideline

(The Endocrine Society) The Endocrine Society today announced an update to its osteoporosis Clinical Practice Guideline to include recommendations for romosozumab, a new medication that was approved last year to treat postmenopausal women at high risk of fracture.